Benign Prostatic Hyperplasia
Semantic Scholar uses AI to extract papers important to this topic.
To revise the 2003 version of the American Urological Association's (AUA) Guideline on the management of benign prostatic… Expand PURPOSE
Benign prostatic hyperplasia (BPH), the most common benign neoplasm in American men, is a chronic condition that is… Expand BACKGROUND
Benign prostatic hyperplasia is commonly treated with alpha-adrenergic-receptor antagonists (alpha-blockers) or 5alpha… Expand The prostate-specific antigen test has been a major factor in increasing awareness and better patient management of prostate… Expand Background Finasteride is known to improve urinary symptoms in men with benign prostatic hyperplasia, but the extent to which the… Expand Background Benign prostatic hyperplasia is a progressive, androgen-dependent disease resulting in enlargement of the prostate… Expand A symptom index for benign prostatic hyperplasia (BPH) was developed and validated by a multidisciplinary measurement committee… Expand There is a strong suspicion among urologists that the prevalence of benign prostatic hyperplasia is higher than has been reported… Expand To compare the clinical usefulness of the serum markers prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP), we… Expand In this study we report the prevalence and growth rate of human benign prostatic hyperplasia with age by combining and analyzing… Expand